The association between cytomegalovirus immune globulin and long-term recipient and graft survival following liver transplantation

Transplant Infectious Disease, 05/04/2012

From the multivariable model, CMVIG with antivirals was associated with increased risk for AR, but decreased risk for graft loss and death; after adjustment, the association between CMVIG alone and mortality was not significant. CMVIG with antivirals is associated with increased risk of AR but greater long–term patient and graft survival after liver transplantation.

Print Article Summary Cat 2 CME Report